These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15230726)
1. Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinical outcome following esophagectomy. France M; Drew PA; Dodd T; Watson DI Dis Esophagus; 2004; 17(2):136-40. PubMed ID: 15230726 [TBL] [Abstract][Full Text] [Related]
2. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508 [TBL] [Abstract][Full Text] [Related]
3. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464 [TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Liu JF; Jamieson G; Wu TC; Zhang SW; Wang QZ; Drew P Dis Esophagus; 2006; 19(5):350-4. PubMed ID: 16984531 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Buskens CJ; Van Rees BP; Sivula A; Reitsma JB; Haglund C; Bosma PJ; Offerhaus GJ; Van Lanschot JJ; Ristimäki A Gastroenterology; 2002 Jun; 122(7):1800-7. PubMed ID: 12055587 [TBL] [Abstract][Full Text] [Related]
6. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663 [TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710 [TBL] [Abstract][Full Text] [Related]
9. Intramucosal esophageal adenocarcinoma: primum non nocere. Li Z; Rice TW; Liu X; Goldblum JR; Williams SJ; Rybicki LA; Murthy SC; Mason DP; Raymond DP; Blackstone EH J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1519-24, 1524.e1-3. PubMed ID: 23158254 [TBL] [Abstract][Full Text] [Related]
10. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors. Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216 [TBL] [Abstract][Full Text] [Related]
11. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186 [TBL] [Abstract][Full Text] [Related]
12. Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia. Buskens CJ; Ten Kate FJ; Obertop H; Izbicki JR; van Lanschot JJ Dis Esophagus; 2008; 21(6):488-95. PubMed ID: 18840133 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy. Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991 [TBL] [Abstract][Full Text] [Related]
14. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101 [TBL] [Abstract][Full Text] [Related]
15. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322 [TBL] [Abstract][Full Text] [Related]